| Sudeep Roy, MD | |
|
1640 N Arlington Heights Rd Ste 210, Arlington Heights, IL 60004-3985 | |
| (877) 967-3223 | |
| (877) 967-3223 |
| Full Name | Sudeep Roy |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology - Otolaryngology/facial Plastic Surgery |
| Location | 1640 N Arlington Heights Rd Ste 210, Arlington Heights, Illinois |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326338526 | NPI | - | NPPES |
| Entity Name | New Horizons Center For Cosmetic Surgery Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073557666 PECOS PAC ID: 4789786146 Enrollment ID: O20070305000053 |
News Archive
Case Western Reserve University has granted an exclusive license on a portfolio of insulin analogs to Thermalin Diabetes, LLC, which has assembled more than $3 million to support the development of these important new drugs.
Thomas Frieden, the director of the Centers for Disease Control and Prevention, announces that the agency will look again at the protocols for hospitals to see if more training or equipment is necessary to protect health care workers and the public.
A clinical decision support system intervention reduced the overall use of antimicrobials for respiratory tract infections such as colds, bronchitis and sinusitis, according to a study in the JAMA: The Journal of the American Medical Association.
The Washington Post: "Opposition to the landmark health care overhaul declined over the past month, to 35 percent from 41 percent, according to the latest results of a tracking poll, reported Thursday. Fifty percent of the public held a favorable view of the law, up slightly from 48 percent a month ago, while 14 percent expressed no opinion about the measure, according to the poll by the Kaiser Family Foundation.
Shield Therapeutics, an independent specialty pharmaceutical company focused on the development of mineral-derived hospital pharmaceuticals, today announces that it has filed an investigational new drug application with the US Food and Drug Administration to initiate a Phase 3 pivotal study of ST10, its novel oral iron-replacement therapy, for the treatment of iron deficiency anaemia in pre-dialysis patients with chronic kidney disease.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sudeep Roy, MD 2030 Harrison St, Glenview, IL 60025-4940 Ph: (650) 814-0291 | Sudeep Roy, MD 1640 N Arlington Heights Rd Ste 210, Arlington Heights, IL 60004-3985 Ph: (877) 967-3223 |
News Archive
Case Western Reserve University has granted an exclusive license on a portfolio of insulin analogs to Thermalin Diabetes, LLC, which has assembled more than $3 million to support the development of these important new drugs.
Thomas Frieden, the director of the Centers for Disease Control and Prevention, announces that the agency will look again at the protocols for hospitals to see if more training or equipment is necessary to protect health care workers and the public.
A clinical decision support system intervention reduced the overall use of antimicrobials for respiratory tract infections such as colds, bronchitis and sinusitis, according to a study in the JAMA: The Journal of the American Medical Association.
The Washington Post: "Opposition to the landmark health care overhaul declined over the past month, to 35 percent from 41 percent, according to the latest results of a tracking poll, reported Thursday. Fifty percent of the public held a favorable view of the law, up slightly from 48 percent a month ago, while 14 percent expressed no opinion about the measure, according to the poll by the Kaiser Family Foundation.
Shield Therapeutics, an independent specialty pharmaceutical company focused on the development of mineral-derived hospital pharmaceuticals, today announces that it has filed an investigational new drug application with the US Food and Drug Administration to initiate a Phase 3 pivotal study of ST10, its novel oral iron-replacement therapy, for the treatment of iron deficiency anaemia in pre-dialysis patients with chronic kidney disease.
› Verified 2 days ago
Dr. Lawrence O Martin, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 1430 North Arlington Heights Rd, Ste 214, Arlington Heights, IL 60004 Phone: 847-255-7773 Fax: 847-255-7803 | |
Dr. Neilkamal Mundi, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 880 W Central Rd Ste 7200, Arlington Heights, IL 60005 Phone: 847-618-4430 Fax: 847-618-0786 |